CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 79 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-03-20 | Molineaux Christopher P. Director | Option exercise | +120 | $0.72 | $86 | 9,718 |
| 2018-03-20 | Molineaux Christopher P. Director | Option exercise | +264 | $1.52 | $401 | 9,982 |
| 2018-03-20 | Molineaux Christopher P. Director | Option exercise · Stock option (right to buy) | −1,993 | 0 | ||
| 2018-03-20 | Molineaux Christopher P. Director | Option exercise · Stock option (right to buy) | −120 | 51 | ||
| 2018-03-20 | Molineaux Christopher P. Director | Option exercise · Stock option (right to buy) | −264 | 198 | ||
| 2018-03-16 | Tullman Stephen A. Director | Other disposition | −94,151 | 0 | ||
| 2018-03-16 | Tullman Stephen A. Director | Other acquisition | +9,018 | 130,807 | ||
| 2018-03-16 | Ali-Jackson Kamil Chief Legal Officer | Other acquisition | +9,018 | 87,677 |
Page 47 of 47 · 928 trades